• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无支架生物主动脉瓣与传统生物主动脉瓣的前瞻性随机评估:对左心室肥厚早期消退的影响。

Prospectively randomized evaluation of stentless versus conventional biological aortic valves: impact on early regression of left ventricular hypertrophy.

作者信息

Walther T, Falk V, Langebartels G, Krüger M, Bernhardt U, Diegeler A, Gummert J, Autschbach R, Mohr F W

机构信息

University Leipzig, Heartcenter, Department of Cardiac Surgery, Leipzig, Germany.

出版信息

Circulation. 1999 Nov 9;100(19 Suppl):II6-10. doi: 10.1161/01.cir.100.suppl_2.ii-6.

DOI:10.1161/01.cir.100.suppl_2.ii-6
PMID:10567271
Abstract

BACKGROUND

The aim of this prospectively randomized study was to evaluate left ventricular hypertrophy and its regression after stentless versus conventional biological aortic valve replacement.

METHODS AND RESULTS

From March 1996 through April 1998, 180 patients were prospectively selected; 106 patients received a stentless aortic valve (SAV), and 74 received a conventional stented bioprosthesis (CSB). Of these patients, 95% and 96%, respectively, had aortic stenosis. Their mean age was 72.3 and 74.8 years, and there were no significant differences in left ventricular function, preoperative pressure gradients, and NYHA functional status. Aortic annulus diameter indexes were comparable at 13.46 (SAV) versus 13.55 (CSB) mm (P=NS). Larger SAVs were implanted because of the oversizing technique. In-hospital mortality (n=3 and 1 for SAV and CSB) was not valve related. At follow-up, all patients were in NYHA class 1 or 2. Baseline end-diastolic left ventricular posterior wall thickness was 15.6 (SAV) and 14.8(CSB) mm (P=NS) and decreased to 11. 8 (SAV) and 13.2 (CSB) mm (P<0.05) at 6 months. Left ventricular mass index was 213 and 202 g/m(2) at baseline (P=NS), whereas after 6 months, it was 141 (SAV) and 170 (CSB) g/m(2) (P<0.05).

CONCLUSIONS

Regression of left ventricular hypertrophy occurs in all patients after aortic valve replacement but is significantly enhanced after SAV implantation. This possibly is due to improved transvalvular hemodynamics.

摘要

背景

本前瞻性随机研究的目的是评估无支架与传统生物主动脉瓣置换术后左心室肥厚及其逆转情况。

方法与结果

1996年3月至1998年4月,前瞻性选取180例患者;106例患者接受无支架主动脉瓣(SAV)置换,74例接受传统带支架生物瓣膜(CSB)置换。这些患者中,分别有95%和96%患有主动脉瓣狭窄。他们的平均年龄分别为72.3岁和74.8岁,左心室功能、术前压力阶差和纽约心脏协会(NYHA)心功能分级无显著差异。主动脉瓣环直径指数在SAV组为13.46mm,CSB组为13.55mm,具有可比性(P=无显著性差异)。由于采用了加大尺寸技术,植入了更大的SAV。住院死亡率(SAV组3例,CSB组1例)与瓣膜无关。随访时,所有患者的心功能分级均为NYHA 1级或2级。基线舒张末期左心室后壁厚度在SAV组为15.6mm,CSB组为14.8mm(P=无显著性差异),6个月时分别降至11.8mm(SAV组)和13.2mm(CSB组)(P<0.05)。左心室质量指数在基线时分别为213g/m²(SAV组)和202g/m²(CSB组)(P=无显著性差异),而6个月后,SAV组为141g/m²,CSB组为170g/m²(P<0.05)。

结论

主动脉瓣置换术后所有患者的左心室肥厚均会发生逆转,但在植入SAV后逆转更为显著。这可能是由于跨瓣血流动力学得到改善。

相似文献

1
Prospectively randomized evaluation of stentless versus conventional biological aortic valves: impact on early regression of left ventricular hypertrophy.无支架生物主动脉瓣与传统生物主动脉瓣的前瞻性随机评估:对左心室肥厚早期消退的影响。
Circulation. 1999 Nov 9;100(19 Suppl):II6-10. doi: 10.1161/01.cir.100.suppl_2.ii-6.
2
Ten-year follow up after prospectively randomized evaluation of stentless versus conventional xenograft aortic valve replacement.
J Heart Valve Dis. 2011 Nov;20(6):681-7.
3
Full-root aortic valve replacement with stentless xenograft achieves superior regression of left ventricular hypertrophy compared to pericardial stented aortic valves.与心包带支架主动脉瓣相比,采用无支架异种移植物进行全根主动脉瓣置换可使左心室肥厚得到更显著的消退。
J Cardiothorac Surg. 2015 Feb 3;10:15. doi: 10.1186/s13019-015-0219-8.
4
Stentless and stented aortic valve replacement in elderly patients: Factors affecting midterm clinical and hemodynamical outcome.老年患者的无支架和带支架主动脉瓣置换术:影响中期临床和血流动力学结果的因素。
Eur J Cardiothorac Surg. 2006 Nov;30(5):706-13. doi: 10.1016/j.ejcts.2006.07.017. Epub 2006 Sep 6.
5
Haemodynamics and left ventricular mass regression: a comparison of the stentless, stented and mechanical aortic valve replacement.血流动力学与左心室质量回归:无支架、有支架及机械主动脉瓣置换术的比较
Eur J Cardiothorac Surg. 1998 May;13(5):572-5. doi: 10.1016/s1010-7940(98)00058-x.
6
Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement.瓣膜置换对主动脉瓣置换术后左心室功能及肥厚变化的影响。
Ann Thorac Surg. 1996 Sep;62(3):683-90. doi: 10.1016/s0003-4975(96)00438-9.
7
Regression of left ventricular hypertrophy after stentless versus conventional aortic valve replacement.无支架与传统主动脉瓣置换术后左心室肥厚的消退情况
Semin Thorac Cardiovasc Surg. 1999 Oct;11(4 Suppl 1):18-21.
8
Prospectively randomized evaluation of stented xenograft hemodynamic function in the aortic position.主动脉位置带支架异种移植物血流动力学功能的前瞻性随机评估。
Circulation. 2004 Sep 14;110(11 Suppl 1):II74-8. doi: 10.1161/01.CIR.0000138947.63799.89.
9
Biological aortic valve replacement: advantages and optimal indications of stentless compared to stented valve substitutes. A review.生物主动脉瓣置换术:与带支架瓣膜替代品相比,无支架瓣膜的优势及最佳适应证。综述
Gen Thorac Cardiovasc Surg. 2018 May;66(5):247-256. doi: 10.1007/s11748-018-0884-3. Epub 2018 Jan 10.
10
Left ventricular mass regression after aortic valve replacement with CryoLife-O'Brien stentless aortic bioprosthesis.使用CryoLife-O'Brien无支架主动脉生物假体进行主动脉瓣置换术后左心室质量的消退
J Heart Valve Dis. 2001 Sep;10(5):603-10.

引用本文的文献

1
Left Ventricular Reverse Remodeling after Surgical Aortic Valve Replacement for Aortic Regurgitation-An Explorative Study.主动脉瓣反流患者行外科主动脉瓣置换术后左心室逆向重构——一项探索性研究
Diseases. 2024 Aug 21;12(8):191. doi: 10.3390/diseases12080191.
2
Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential.心脏肥大在健康和疾病中的消退:机制和治疗潜力。
Nat Rev Cardiol. 2023 May;20(5):347-363. doi: 10.1038/s41569-022-00806-6. Epub 2023 Jan 4.
3
Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy.
血管紧张素 II 诱导的心肌肥厚信号转导机制。
Cells. 2022 Oct 22;11(21):3336. doi: 10.3390/cells11213336.
4
Mitral regurgitation after transcatheter aortic valve replacement.经导管主动脉瓣置换术后二尖瓣反流
J Thorac Dis. 2020 May;12(5):2926-2935. doi: 10.21037/jtd.2020.01.69.
5
Should a surgeon comply with hospital administration's demand to change valve preference?外科医生应该遵守医院管理部门更换瓣膜偏好的要求吗?
J Thorac Cardiovasc Surg. 2018 Dec;156(6):2210-2215. doi: 10.1016/j.jtcvs.2018.07.044. Epub 2018 Jul 29.
6
Hemodynamics of Pericardial Aortic Valves: Contemporary Stented versus Stentless Valves in a Matched Comparison.心包主动脉瓣的血流动力学:当代带支架瓣膜与无支架瓣膜的匹配比较
Ann Thorac Cardiovasc Surg. 2017 Dec 20;23(6):298-303. doi: 10.5761/atcs.oa.17-00061. Epub 2017 Sep 8.
7
Influence of the tilt angle of Percutaneous Aortic Prosthesis on Velocity and Shear Stress Fields.经皮主动脉假体倾斜角度对速度和剪切应力场的影响。
Arq Bras Cardiol. 2017 Jul-Aug;109(3):231-240. doi: 10.5935/abc.20170115.
8
Durability of prostheses for transcatheter aortic valve implantation.经导管主动脉瓣植入术的假体耐久性。
Nat Rev Cardiol. 2016 Jun;13(6):360-7. doi: 10.1038/nrcardio.2016.43. Epub 2016 Apr 7.
9
Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.心肌肥厚预处理通过上调S100A8/A9减轻心肌细胞肥大并减缓向心力衰竭的进展。
Circulation. 2015 Apr 28;131(17):1506-17; discussion 1517. doi: 10.1161/CIRCULATIONAHA.114.013789. Epub 2015 Mar 27.
10
Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations.经导管主动脉瓣置换术后严重左心室肥厚的早期消退与住院次数减少相关。
JACC Cardiovasc Interv. 2014 Jun;7(6):662-73. doi: 10.1016/j.jcin.2014.02.011.